Literature DB >> 34189847

A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya.

Helgar Musyoki1, Parinita Bhattacharjee2,3, Keith Sabin4, Ed Ngoksin5, Tisha Wheeler6, Gina Dallabetta7.   

Abstract

INTRODUCTION: Key populations (KP) continue to account for high HIV incidence globally. Still, prioritization of KP in the national HIV prevention response remains insufficient, leading to their suboptimal access to HIV programmes. This commentary aims to share Kenya's challenges and successes in achieving 2020 global HIV targets and scaling up the KP programme in the last decade. DISCUSSION: The KP programme in Kenya has scaled up in the last decade with the inclusion of female sex workers (FSW), men who have sex with men (MSM), people who inject drugs (PWID), transgender people and people in prisons as priority populations in the national HIV response. KP coverage based on official size estimates for FSW is 73%, for MSM is 82%, for PWID through needle syringe programme (NSP) is 71%, and through opioid substitution therapy (OST) is 26% and for transgender people is 5%. The service outcomes for KP have been relatively strong in prevention with high condom use at last paid sex for FSW (92%) and use of sterile equipment among PWID (88%), though condom use at last sex with a non-regular partner among MSM (78%) is still low. The KP programme has not met care continuum targets for all subpopulations with low case findings. The national KP programme led by the Ministry of Health has scaled up the programme through (a) strategic partnerships with KP-led and competent organizations, researchers and donors; (b) development of policy guidance and programme standards; (c) continuous sensitization and advocacy to garner support; (d) development of national reporting systems, among others. However, the programme is still struggling with uncertain size estimates; lack of updated bio-behavioural survey data; inadequate scale-up of interventions among transgender people and people in prison settings; gaps in reaching adolescent and young KP, and effectively addressing structural barriers like violence and stigma.
CONCLUSIONS: To reach the ambitious global HIV targets, sufficient coverage of KP with quality HIV programmes is critical. Despite scaling up the KP programme, Kenya has not yet achieved the 2020 global HIV targets and needs more efforts to scale-up quality programmes for KP who are underserved in the HIV response.
© 2021 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Entities:  

Keywords:  2020 global HIV targets; HIV programmes; Kenya; key populations; scale

Year:  2021        PMID: 34189847     DOI: 10.1002/jia2.25729

Source DB:  PubMed          Journal:  J Int AIDS Soc        ISSN: 1758-2652            Impact factor:   5.396


  4 in total

1.  Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.

Authors:  Natasha T Ludwig-Barron; Brandon L Guthrie; Loice Mbogo; David Bukusi; William Sinkele; Esther Gitau; Carey Farquhar; Aliza Monroe-Wise
Journal:  Harm Reduct J       Date:  2021-12-18

2.  Capacity and Readiness Assessment of Healthcare Facilities for Digital Health Interventions Against Tuberculosis and HIV in Addis Ababa, Ethiopia.

Authors:  Emnet Getachew; Yimtubezinash Woldeamanuel; Tsegahun Manyazewal
Journal:  Front Digit Health       Date:  2022-02-28

3.  Strategies to Identify and Reach Young Women Who Sell Sex With HIV Prevention and Care Services: Lessons Learnt From the Implementation of DREAMS Services in Two Cities in Zimbabwe.

Authors:  Sungai T Chabata; Rumbidzo Makandwa; Bernadette Hensen; Phillis Mushati; Tarisai Chiyaka; Sithembile Musemburi; Joanna Busza; Sian Floyd; Isolde Birdthistle; James R Hargreaves; Frances M Cowan
Journal:  JMIR Public Health Surveill       Date:  2022-07-27

4.  HIV prevention programme with young women who sell sex in Mombasa, Kenya: learnings for scale-up.

Authors:  Parinita Bhattacharjee; Abednego Musau; Griffins Manguro; Patricia Ongwen; Jane Mutegi; Japheth Kioko; Lisa Lazarus; Shajy Isac; Helgar Musyoki; Jan Hontelez; Daniel Were
Journal:  J Int AIDS Soc       Date:  2022-08       Impact factor: 6.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.